Simon Peter Cooper

Insider Reports History

Entity
Individual
Location
C/O Keros Therapeutics, Inc., 99 Hayden Ave., Building E, Suite 120, Lexington, MA
Signature
/s/ Robert Farrell, Attorney-in-Fact for Simon Peter Cooper
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Simon Peter Cooper:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Morphic Holding, Inc. CMO Restricted Stock Unit 7K $192K $27.49 Mar 18, 2024 Direct
Morphic Holding, Inc. CMO Restricted Stock Unit 0 $0 $55.79 Aug 16, 2024 Direct
Morphic Holding, Inc. CMO Employee Stock Options (right to buy) 170K Mar 18, 2024 Direct
Keros Therapeutics, Inc. CHIEF MEDICAL OFFICER Employee Stock Option (right to buy) 40K Feb 13, 2024 Direct
Morphic Holding, Inc. CMO Stock Option (Right to Buy) 0 Aug 16, 2024 Direct

Insider Reports Filed by Simon Peter Cooper

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MORF Morphic Holding, Inc. Aug 16, 2024 3 $0 4 Aug 20, 2024 CMO
MORF Morphic Holding, Inc. Mar 18, 2024 3 $0 4 Mar 19, 2024 CMO
MORF Morphic Holding, Inc. Mar 18, 2024 0 $0 3 Mar 19, 2024 CMO
KROS Keros Therapeutics, Inc. Feb 13, 2024 1 $0 4 Feb 15, 2024 CHIEF MEDICAL OFFICER
KROS Keros Therapeutics, Inc. Feb 16, 2023 1 $0 4 Feb 17, 2023 Chief Medical Officer
KROS Keros Therapeutics, Inc. Jan 21, 2022 1 $0 4 Jan 25, 2022 Chief Medical Officer
KROS Keros Therapeutics, Inc. Aug 10, 2021 1 $0 4 Aug 11, 2021 Chief Medical Officer
KROS Keros Therapeutics, Inc. Aug 2, 2021 0 $0 3 Aug 11, 2021 Chief Medical Officer